New Name for PCOS Reflects 'Whole-Body' Nature of Condition

Health specialists in Jersey are advocating for a shift in perspective regarding a metabolic disorder that impacts over 170 million women worldwide, arguing that a recent name change better captures its systemic nature. While Polycystic Ovary Syndrome (PCOS) has long been the standard term, the International PCOS Network officially introduced the new designation, Polyendocrine Metabolic Ovarian Syndrome (PMOS), on May 12. The organization hopes this update will enhance public comprehension, thereby facilitating earlier diagnosis and more effective treatment strategies.

Jessica Pinel, a nutritionist and chair of PCOS Jersey, emphasized that the previous terminology was restrictive. Diagnosed three years ago after incurring over £3,000 in treatment costs, Pinel noted that "PCOS" implies the disorder is confined to the ovaries. In reality, she described it as a comprehensive whole-body condition. "We know that it is a full body condition," Pinel stated, highlighting the diverse and often debilitating symptoms her clients experience.

According to the NHS, individuals with the condition typically exhibit elevated male hormone levels, which can lead to irregular menstruation, weight gain, and other complications. Pinel listed the wide spectrum of effects she observes in her practice, including fatigue, unwanted hair growth, acne, "brain fog," irregular periods, and infertility. "It is that full-body condition with a range of different symptoms," she explained, expressing hope that the rebranding will help women access appropriate support for this complex array of issues.

Pinel also raised concerns about the quality of information available to patients. She warned against relying on social media platforms like TikTok, Instagram, and Facebook for medical advice, citing the prevalence of misinformation. This issue was highlighted in 2024 when the BBC uncovered influencers marketing fraudulent cures for the syndrome. Consequently, Pinel urged individuals suspecting they have the condition to consult professionals and seek second opinions if necessary. Recalling her own diagnostic journey, she advised, "If you feel like you're not being seen or heard, then please go and seek that second opinion because you deserve it."

Dr. Jessica Langtree-Marsh, a Jersey GP, echoed the sentiment that the condition is frequently overlooked. She criticized the medical community for often dismissing PCOS until a patient desires pregnancy, stating, "Come back when you want to have a baby and we'll fix it then." Instead, she argued it should be viewed as a lifelong health issue. Dr. Langtree-Marsh, whose government is working on a women’s health strategy due for release later this year, believes the new name could encourage broader treatment approaches. She suggested moving beyond a sole reliance on contraceptive pills toward metabolic medications that address the root causes.

The history of the condition dates back 70 years to when surgeons Dr. Irving Stein and Dr. Michael Leventhal identified the syndrome in women experiencing amenorrhea, noting the distinct appearance of their ovaries. Originally termed Stein-Leventhal Syndrome, it was later renamed PCOS. Dr. Langtree-Marsh explained that while the old name acknowledged ovarian involvement, it failed to reflect the systemic reality. Although she admitted the new acronym "doesn't exactly roll off the tongue," she welcomed the shift in definition. "The rebranded PMOS is trying to appreciate that it affects women more generally rather than just the ovaries, so that it's a whole body condition," she concluded.

Source: BBC News Generated at: 2026-05-26 05:27:03 UTC